Nephros
NEPH
16 hedge funds and large institutions have $537M invested in Nephros in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 4 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 17 → 16 (-1)
8.87% less ownership
Funds ownership: 50.85% → 41.98% (-8.9%)
18% less capital invested
Capital invested by funds: $656M → $537M (-$119M)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$96.4K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
+$66K |
| 3 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$63.8K |
| 4 |
CF
Cantor Fitzgerald
New York
|
+$60.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$48.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Cowen Prime Advisors
New York
|
-$2.62M |
| 2 |
SC
Samjo Capital
New York
|
-$2.51M |
| 3 |
TCWM
Total Clarity Wealth Management
St. Charles,
Illinois
|
-$4K |
| 4 |
BlackRock
New York
|
-$3.51K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1K |
NEPH Hedge Fund Activity: Q1 2022 in Review
16 of the 6,361 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q1 2022, worth a combined $537M — down 18% from $656M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NEPH and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 7 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $96.4K. The largest seller was Cowen Prime Advisors, cutting an estimated $2.62M.
- 16 institutional investors held Nephros (NEPH) as of Q1 2022, down from 17 in Q4 2021.
- Funds reported $537M of Nephros stock for Q1 2022, down 18% quarter-over-quarter.
- 3 funds opened new Nephros positions in Q1 2022 and 4 closed out, a net change of -1 holder.
- The largest Nephros buyer in Q1 2022 was Renaissance Technologies, an estimated $96.4K added.
- The largest Nephros seller in Q1 2022 was Cowen Prime Advisors, an estimated $2.62M sold.
Based on aggregated 13F filings for Q1 2022.